Anti-gangliosides – Buhlmann Diagnostics Corp

Tag: Anti-gangliosides

Join BUHLMANN at AACC 2018

BÜHLMANN fCAL® ELISA, accurate, precise, efficient calprotectin testing Health Canada License: 80726 US:  BÜHLMANN fCAL® ELISA is FDA 510(k) cleared. For in vitro Diagnostic Use. Quantum Blue® platform offering rapid and quantitative results for fecal calprotectin, serum calprotectin, CRP, serum infliximab trough levels, and serum adalimumab trough levels (Additional trough level assays coming soon!) Health Canada Licenses: Quantum Blue®  fCAL: 83477, Quantum Blue® fCAL extended: 100161 US: Research Use Only. Not
Continue Reading

BUHLMANN LabSense News: Fall 2016 Edition

BUHLMANN Diagnostics Corp is proud to present the very first edition of our newsletter. View the latest information, new happenings, products highlights, citations, and promotions in the BUHLMANN LabSense News.  Here you will also be able to access valuable resources, applications, and other newsworthy items specific to fields of in vitro diagnostics and scientific research. In this
Continue Reading

Prevalence, Specificity and Functionality of Anti-Ganglioside Antibodies in Neuropathy Associated with IgM Monoclonal Gammopathy

Anti-MAG Autoantibodies ELISA Citation: Stork AC et al.; Prevalence, specificity and functionality of anti-ganglioside antibodies in Neuropathy associated with IgM monoclonal gammopathy. J Neuroimmunol. 2014 Mar 15; 268(1-2): 89-94. PMID:24529728 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

The Presence of Mycoplasma Pneumoniae Infection and GM1 Ganglioside Antibodies in Guillain-Barré Syndrome

BÜHLMANN GanglioCombi ELISA Citation: Sharma MB et al.: The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome. J Infect Dev Ctries. 2011 Jul 4; 5(6):459-64. PMID:21727645.   Highlight from this Publication "Significant difference in levels of anti GM1 ganglioside antibodies (IgG & IgM) was seen between GBS patients and non-neurological controls, highlighting
Continue Reading

Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited

BÜHLMANN GanglioCombi® MAG ELISA Citation Kollewe K et al.; Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited. PLoS One. 2015 Apr 14; 10(4):e0125339.     Highlight from this Publication "In the present study, we describe for the first time the utilization of a state of the art-ELISA assay to obtain reliable data on the occurrence of IgG
Continue Reading